Narek Shaverdian - Concepedia

Author

Narek Shaverdian

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Andrew D Seidman, N Shaverdian, N. Shaverdian, NAREK SHAVERDIAN, Narek Shaverdian

454

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of California, Los Angeles Cornell University Dana-Farber Cancer Institute The University of Texas MD Anderson Cancer Center

About

Narek Shaverdian is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	2.4K
2	Health Sciences	13	13	691
3	Engineering	1	1	22
4	Natural Sciences	1	1	103
5	Nursing	1	1	15

Narek Shaverdian

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan, The Lancet Oncology Radiation MedicineRadiation TherapyMedicinePathologyKeynote-001 Phase 1	2017	1.1K
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer Amar U. Kishan, Audrey Dang, Alan J. Katz, JAMA Network Open	2019	302
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning Jérémie Calais, Johannes Czernin, Minsong Cao, Journal of Nuclear Medicine	2017	260
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian, The Lancet Adaptive RadiotherapyRadiation TherapyMedicineOligoprogressive Breast CancerBreast Cancer	2023	214
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy Stephen A. Rosenberg, Lauren E. Henke, Narek Shaverdian, Advances in Radiation Oncology Adaptive RadiotherapyRadiation MedicineHepatologyRadiation TherapyMedical Imaging	2018	157
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines Rhea N. Coler, Susan L. Baldwin, Narek Shaverdian, PLoS ONE	2010	145
Online Adaptive Radiation Therapy: Implementation of a New Process of Care James Lamb, Minsong Cao, Amar U. Kishan, Cureus	2017	117
Potential Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer Jérémie Calais, Amar U. Kishan, Minsong Cao, Journal of Nuclear Medicine	2018	110
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations Ryan C. Anderson, Christopher B. Fox, Timothy S. Dutill, Colloids and Surfaces B Biointerfaces Biological ActivityBiochemistryNatural SciencesMedicineMechanism Of Action	2009	103
Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman, Cancer Immunology Research	2018	102

Page 1